

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.18560900 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.92290887 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.47580983 |
| 4 | locomotory exploration behavior (GO:0035641) | 5.43420031 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.35427810 |
| 6 | * synaptic vesicle exocytosis (GO:0016079) | 5.25967397 |
| 7 | vocalization behavior (GO:0071625) | 5.25223022 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.01909560 |
| 9 | glutamate secretion (GO:0014047) | 4.97878571 |
| 10 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.94410879 |
| 11 | layer formation in cerebral cortex (GO:0021819) | 4.78299863 |
| 12 | protein localization to synapse (GO:0035418) | 4.77181512 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.70260227 |
| 14 | protein localization to endosome (GO:0036010) | 4.60435518 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.56503109 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.43426300 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.41976925 |
| 18 | exploration behavior (GO:0035640) | 4.41544372 |
| 19 | * neurotransmitter secretion (GO:0007269) | 4.39092073 |
| 20 | neuron cell-cell adhesion (GO:0007158) | 4.38369410 |
| 21 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.23620627 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 4.22182914 |
| 23 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.10307019 |
| 24 | proline transport (GO:0015824) | 4.05328662 |
| 25 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 4.01464586 |
| 26 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.97785727 |
| 27 | glutamate receptor signaling pathway (GO:0007215) | 3.91513439 |
| 28 | dendritic spine morphogenesis (GO:0060997) | 3.90874762 |
| 29 | cellular potassium ion homeostasis (GO:0030007) | 3.89374804 |
| 30 | gamma-aminobutyric acid transport (GO:0015812) | 3.88294424 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 3.85863340 |
| 32 | neuronal action potential propagation (GO:0019227) | 3.82678902 |
| 33 | positive regulation of synapse maturation (GO:0090129) | 3.81756684 |
| 34 | sodium ion export (GO:0071436) | 3.79324160 |
| 35 | neuron-neuron synaptic transmission (GO:0007270) | 3.75146759 |
| 36 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.71027002 |
| 37 | activation of protein kinase A activity (GO:0034199) | 3.70630179 |
| 38 | long-term memory (GO:0007616) | 3.66470425 |
| 39 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.65665525 |
| 40 | neuron recognition (GO:0008038) | 3.63532912 |
| 41 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.60719694 |
| 42 | positive regulation of membrane potential (GO:0045838) | 3.55300363 |
| 43 | * neurotransmitter transport (GO:0006836) | 3.55242594 |
| 44 | regulation of early endosome to late endosome transport (GO:2000641) | 3.53139404 |
| 45 | dendrite morphogenesis (GO:0048813) | 3.47384945 |
| 46 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.47261295 |
| 47 | regulation of postsynaptic membrane potential (GO:0060078) | 3.47156026 |
| 48 | synaptic vesicle endocytosis (GO:0048488) | 3.46474242 |
| 49 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.45854204 |
| 50 | prepulse inhibition (GO:0060134) | 3.44688915 |
| 51 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.39324568 |
| 52 | regulation of vesicle fusion (GO:0031338) | 3.38693166 |
| 53 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.36059902 |
| 54 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.33280163 |
| 55 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.32160400 |
| 56 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.31557262 |
| 57 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.30569156 |
| 58 | transmission of nerve impulse (GO:0019226) | 3.30125712 |
| 59 | regulation of neurotransmitter secretion (GO:0046928) | 3.29490286 |
| 60 | neuromuscular process controlling balance (GO:0050885) | 3.28639052 |
| 61 | axonal fasciculation (GO:0007413) | 3.27325362 |
| 62 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.26430349 |
| 63 | mating behavior (GO:0007617) | 3.24628068 |
| 64 | regulation of synaptic plasticity (GO:0048167) | 3.22879008 |
| 65 | * regulation of neurotransmitter levels (GO:0001505) | 3.21694000 |
| 66 | cell communication by electrical coupling (GO:0010644) | 3.19694691 |
| 67 | vesicle transport along microtubule (GO:0047496) | 3.17066178 |
| 68 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.16165244 |
| 69 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.14942400 |
| 70 | barbed-end actin filament capping (GO:0051016) | 3.14730294 |
| 71 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.14647811 |
| 72 | long-term synaptic potentiation (GO:0060291) | 3.14006009 |
| 73 | response to histamine (GO:0034776) | 3.12555941 |
| 74 | synapse assembly (GO:0007416) | 3.12538709 |
| 75 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.11533360 |
| 76 | regulation of ARF protein signal transduction (GO:0032012) | 3.11306413 |
| 77 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.08129666 |
| 78 | membrane hyperpolarization (GO:0060081) | 3.07687025 |
| 79 | innervation (GO:0060384) | 3.07554456 |
| 80 | postsynaptic membrane organization (GO:0001941) | 3.05445039 |
| 81 | regulation of neurotransmitter transport (GO:0051588) | 3.04724563 |
| 82 | positive regulation of neurotransmitter transport (GO:0051590) | 3.03136595 |
| 83 | auditory behavior (GO:0031223) | 3.02382222 |
| 84 | glycine transport (GO:0015816) | 3.01679583 |
| 85 | membrane depolarization (GO:0051899) | 2.99344943 |
| 86 | response to auditory stimulus (GO:0010996) | 2.96117343 |
| 87 | cell migration in hindbrain (GO:0021535) | 2.94465694 |
| 88 | social behavior (GO:0035176) | 2.93799068 |
| 89 | intraspecies interaction between organisms (GO:0051703) | 2.93799068 |
| 90 | mannose metabolic process (GO:0006013) | 2.93783764 |
| 91 | neuromuscular process controlling posture (GO:0050884) | 2.93711897 |
| 92 | signal complex assembly (GO:0007172) | 2.93518737 |
| 93 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.93394400 |
| 94 | organelle transport along microtubule (GO:0072384) | 2.93113815 |
| 95 | membrane depolarization during action potential (GO:0086010) | 2.92638845 |
| 96 | cerebellar Purkinje cell layer development (GO:0021680) | 2.92352577 |
| 97 | clathrin coat assembly (GO:0048268) | 2.90913705 |
| 98 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.90303057 |
| 99 | cerebellar granule cell differentiation (GO:0021707) | 2.90164351 |
| 100 | regulation of synapse maturation (GO:0090128) | 2.89803970 |
| 101 | synapse organization (GO:0050808) | 2.87730537 |
| 102 | axon cargo transport (GO:0008088) | 2.87630410 |
| 103 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.87483839 |
| 104 | behavioral fear response (GO:0001662) | 2.87370218 |
| 105 | behavioral defense response (GO:0002209) | 2.87370218 |
| 106 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.87011678 |
| 107 | dopamine receptor signaling pathway (GO:0007212) | 2.86246030 |
| 108 | learning (GO:0007612) | 2.85337367 |
| 109 | activation of Rac GTPase activity (GO:0032863) | 2.84544511 |
| 110 | regulation of ARF GTPase activity (GO:0032312) | 2.84333570 |
| 111 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.83794371 |
| 112 | protein retention in ER lumen (GO:0006621) | 2.80015033 |
| 113 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.73259938 |
| 114 | amino acid import (GO:0043090) | 2.73014766 |
| 115 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.71695419 |
| 116 | cell-cell junction maintenance (GO:0045217) | 2.71563089 |
| 117 | response to peptidoglycan (GO:0032494) | 2.70544263 |
| 118 | regulation of regulated secretory pathway (GO:1903305) | 2.67351889 |
| 119 | stress fiber assembly (GO:0043149) | 2.66121481 |
| 120 | adherens junction assembly (GO:0034333) | 2.64342126 |
| 121 | COPI coating of Golgi vesicle (GO:0048205) | 2.63391715 |
| 122 | Golgi transport vesicle coating (GO:0048200) | 2.63391715 |
| 123 | regulation of leukocyte degranulation (GO:0043300) | 2.62720584 |
| 124 | L-amino acid import (GO:0043092) | 2.61458991 |
| 125 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.61456582 |
| 126 | positive regulation of receptor recycling (GO:0001921) | 2.60390840 |
| 127 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.59607262 |
| 128 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.59030989 |
| 129 | positive regulation of protein dephosphorylation (GO:0035307) | 2.58871698 |
| 130 | cell-substrate adherens junction assembly (GO:0007045) | 2.56996282 |
| 131 | focal adhesion assembly (GO:0048041) | 2.56996282 |
| 132 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.54637425 |
| 133 | cell-substrate junction assembly (GO:0007044) | 2.53208657 |
| 134 | positive regulation by symbiont of host defense response (GO:0052509) | 2.52511092 |
| 135 | modulation by symbiont of host defense response (GO:0052031) | 2.52511092 |
| 136 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.52511092 |
| 137 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.52511092 |
| 138 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.52511092 |
| 139 | modulation by symbiont of host immune response (GO:0052553) | 2.52511092 |
| 140 | modulation by symbiont of host cellular process (GO:0044068) | 2.50863443 |
| 141 | semaphorin-plexin signaling pathway (GO:0071526) | 2.50709254 |
| 142 | cortical actin cytoskeleton organization (GO:0030866) | 2.49609986 |
| 143 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.49319771 |
| 144 | macrophage activation involved in immune response (GO:0002281) | 2.47980899 |
| 145 | negative regulation of cell killing (GO:0031342) | 2.47403760 |
| 146 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47403760 |
| 147 | regulation of defense response to virus by virus (GO:0050690) | 2.46638037 |
| 148 | hemidesmosome assembly (GO:0031581) | 2.39931827 |
| 149 | response to laminar fluid shear stress (GO:0034616) | 2.38214890 |
| 150 | response to muramyl dipeptide (GO:0032495) | 2.37764372 |
| 151 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.34726360 |
| 152 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.34282236 |
| 153 | positive regulation of Rap GTPase activity (GO:0032854) | 2.34193348 |
| 154 | negative regulation of fatty acid transport (GO:2000192) | 2.34173640 |
| 155 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.33140941 |
| 156 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.32626160 |
| 157 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.30032507 |
| 158 | hypotonic response (GO:0006971) | 2.29006280 |
| 159 | positive regulation of regulated secretory pathway (GO:1903307) | 2.28435701 |
| 160 | glucose 6-phosphate metabolic process (GO:0051156) | 2.27647667 |
| 161 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.26629280 |
| 162 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.24172270 |
| 163 | detection of other organism (GO:0098543) | 2.24057779 |
| 164 | regulation of extracellular matrix disassembly (GO:0010715) | 2.23117161 |
| 165 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.21168923 |
| 166 | modulation by virus of host process (GO:0019054) | 2.20392653 |
| 167 | regulation of cellular amide metabolic process (GO:0034248) | 2.19273988 |
| 168 | cortical cytoskeleton organization (GO:0030865) | 2.19171652 |
| 169 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.18428651 |
| 170 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.18428651 |
| 171 | adenosine receptor signaling pathway (GO:0001973) | 2.17706677 |
| 172 | modulation by virus of host morphology or physiology (GO:0019048) | 2.17170755 |
| 173 | actin filament bundle organization (GO:0061572) | 2.16636026 |
| 174 | actin filament bundle assembly (GO:0051017) | 2.16636026 |
| 175 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.16088566 |
| 176 | potassium ion homeostasis (GO:0055075) | 2.15384846 |
| 177 | receptor recycling (GO:0001881) | 2.15353271 |
| 178 | protein targeting to plasma membrane (GO:0072661) | 2.14956505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.76443749 |
| 2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.50185245 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.18282994 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.18106260 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08374018 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.07804579 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.01854031 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.81308268 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.69956508 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.69956508 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.69463533 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69102702 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.61680370 |
| 14 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.59799187 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.58326166 |
| 16 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.55471131 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52819342 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.51705842 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.48101614 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.44575165 |
| 21 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.44526242 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38977634 |
| 23 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.31914144 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.31163398 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.26284682 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24556936 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.24403715 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.21471471 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.20957244 |
| 30 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.20330192 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.19734141 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.13907812 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.13576265 |
| 34 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.12363886 |
| 35 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.12222046 |
| 36 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 2.11511342 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10049299 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.04181406 |
| 39 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.02185749 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.98314795 |
| 41 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.94729589 |
| 42 | MYC_22102868_ChIP-Seq_BL_Human | 1.91890927 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.88677294 |
| 44 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.83569317 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.77465365 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.67722590 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.62274759 |
| 48 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.60453271 |
| 49 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.59355625 |
| 50 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.57345066 |
| 51 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56980931 |
| 52 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.56173539 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56000460 |
| 54 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.52428672 |
| 55 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.50674991 |
| 56 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50650057 |
| 57 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.50093512 |
| 58 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.50021903 |
| 59 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.49936739 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.46410422 |
| 61 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.46221957 |
| 62 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45831240 |
| 63 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.45543769 |
| 64 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.44890130 |
| 65 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.44633719 |
| 66 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41718380 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39734963 |
| 68 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.39406096 |
| 69 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37695284 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.36490045 |
| 71 | P68_20966046_ChIP-Seq_HELA_Human | 1.35614717 |
| 72 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.35034992 |
| 73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.34750234 |
| 74 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34393227 |
| 75 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34302475 |
| 76 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.33637669 |
| 77 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.32834980 |
| 78 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.32789586 |
| 79 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.31800363 |
| 80 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.31701244 |
| 81 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.29566697 |
| 82 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29015155 |
| 83 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28793156 |
| 84 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.28655639 |
| 85 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.28644954 |
| 86 | AR_19668381_ChIP-Seq_PC3_Human | 1.28149484 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.28127871 |
| 88 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.27937295 |
| 89 | KDM2B_26808549_Chip-Seq_K562_Human | 1.27711990 |
| 90 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.27168314 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26686743 |
| 92 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.25116223 |
| 93 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.24918853 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24760419 |
| 95 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23113710 |
| 96 | P300_19829295_ChIP-Seq_ESCs_Human | 1.22480848 |
| 97 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.21990229 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21984332 |
| 99 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21775470 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.20952591 |
| 101 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20842090 |
| 102 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20821088 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 1.20140736 |
| 104 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.19915228 |
| 105 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.19687282 |
| 106 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.19569520 |
| 107 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.18516647 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.18371054 |
| 109 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.18041317 |
| 110 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17980865 |
| 111 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.17844213 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17627390 |
| 113 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.17572265 |
| 114 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17277495 |
| 115 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.16874061 |
| 116 | STAT3_23295773_ChIP-Seq_U87_Human | 1.16593184 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.16267859 |
| 118 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.13746864 |
| 119 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.13379720 |
| 120 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.11716171 |
| 121 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.11042777 |
| 122 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10845857 |
| 123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10643640 |
| 124 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10303179 |
| 125 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.10227626 |
| 126 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.10077575 |
| 127 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.09677480 |
| 128 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08377667 |
| 129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07435952 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06968784 |
| 131 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05857848 |
| 132 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.05316159 |
| 133 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05108040 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05075800 |
| 135 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04905693 |
| 136 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.03735932 |
| 137 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03126276 |
| 138 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.02918308 |
| 139 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02484071 |
| 140 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01893602 |
| 141 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01569811 |
| 142 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01458967 |
| 143 | TCF4_23295773_ChIP-Seq_U87_Human | 1.01160249 |
| 144 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00820695 |
| 145 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99833267 |
| 146 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99383388 |
| 147 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98992736 |
| 148 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.98060135 |
| 149 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97335138 |
| 150 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97314107 |
| 151 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.95463602 |
| 152 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94915622 |
| 153 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.94910407 |
| 154 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94562235 |
| 155 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.94355822 |
| 156 | * MAF_26560356_Chip-Seq_TH2_Human | 0.94308511 |
| 157 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93895449 |
| 158 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.93810882 |
| 159 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.93733115 |
| 160 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93173064 |
| 161 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92081378 |
| 162 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.92003782 |
| 163 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91904271 |
| 164 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.91811408 |
| 165 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.91785501 |
| 166 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.91615840 |
| 167 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91493492 |
| 168 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90961342 |
| 169 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88950478 |
| 170 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88515971 |
| 171 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88098478 |
| 172 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88052410 |
| 173 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.87682154 |
| 174 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87396076 |
| 175 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.85327129 |
| 176 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.83110373 |
| 177 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82687612 |
| 178 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82252717 |
| 179 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82045881 |
| 180 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.81709186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.43046543 |
| 2 | MP0003880_abnormal_central_pattern | 4.69559365 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 4.24024307 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.23559888 |
| 5 | MP0004270_analgesia | 3.68595470 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.36153174 |
| 7 | MP0009745_abnormal_behavioral_response | 3.35283919 |
| 8 | MP0005058_abnormal_lysosome_morphology | 3.22068167 |
| 9 | MP0002064_seizures | 3.16737459 |
| 10 | MP0009046_muscle_twitch | 3.15775210 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.99905836 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.87562265 |
| 13 | MP0008260_abnormal_autophagy | 2.84436715 |
| 14 | MP0005451_abnormal_body_composition | 2.81155019 |
| 15 | MP0005409_darkened_coat_color | 2.80620753 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.77928765 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.72759134 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.60918465 |
| 19 | MP0002822_catalepsy | 2.57040715 |
| 20 | MP0002272_abnormal_nervous_system | 2.45333808 |
| 21 | * MP0001486_abnormal_startle_reflex | 2.38341777 |
| 22 | MP0009840_abnormal_foam_cell | 2.34935249 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.33439964 |
| 24 | MP0003436_decreased_susceptibility_to | 2.27393665 |
| 25 | MP0003566_abnormal_cell_adhesion | 2.20123286 |
| 26 | MP0002735_abnormal_chemical_nociception | 2.19127165 |
| 27 | MP0001501_abnormal_sleep_pattern | 2.14594888 |
| 28 | MP0002736_abnormal_nociception_after | 2.12398872 |
| 29 | MP0001440_abnormal_grooming_behavior | 2.09862666 |
| 30 | MP0002733_abnormal_thermal_nociception | 2.09335903 |
| 31 | MP0001849_ear_inflammation | 2.06141412 |
| 32 | MP0003300_gastrointestinal_ulcer | 2.05236285 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 2.03363958 |
| 34 | MP0003329_amyloid_beta_deposits | 1.99633976 |
| 35 | MP0008569_lethality_at_weaning | 1.97687896 |
| 36 | MP0002909_abnormal_adrenal_gland | 1.95463869 |
| 37 | * MP0002067_abnormal_sensory_capabilities | 1.95385428 |
| 38 | MP0002184_abnormal_innervation | 1.95044259 |
| 39 | MP0001970_abnormal_pain_threshold | 1.93779310 |
| 40 | MP0003453_abnormal_keratinocyte_physiol | 1.92567356 |
| 41 | MP0000778_abnormal_nervous_system | 1.92440327 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.88823405 |
| 43 | MP0004858_abnormal_nervous_system | 1.83067819 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.81422555 |
| 45 | MP0002557_abnormal_social/conspecific_i | 1.76478050 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.72932862 |
| 47 | MP0003091_abnormal_cell_migration | 1.72880790 |
| 48 | MP0004947_skin_inflammation | 1.71725025 |
| 49 | * MP0004924_abnormal_behavior | 1.70483092 |
| 50 | * MP0005386_behavior/neurological_phenoty | 1.70483092 |
| 51 | MP0003123_paternal_imprinting | 1.70247277 |
| 52 | MP0006276_abnormal_autonomic_nervous | 1.65925388 |
| 53 | MP0000955_abnormal_spinal_cord | 1.58212578 |
| 54 | MP0001348_abnormal_lacrimal_gland | 1.48668145 |
| 55 | MP0002796_impaired_skin_barrier | 1.47983958 |
| 56 | * MP0002882_abnormal_neuron_morphology | 1.47813018 |
| 57 | MP0004885_abnormal_endolymph | 1.44737098 |
| 58 | MP0003787_abnormal_imprinting | 1.43557223 |
| 59 | MP0003122_maternal_imprinting | 1.41768445 |
| 60 | MP0003879_abnormal_hair_cell | 1.40664672 |
| 61 | * MP0002066_abnormal_motor_capabilities/c | 1.40467594 |
| 62 | MP0001984_abnormal_olfaction | 1.36574850 |
| 63 | MP0000858_altered_metastatic_potential | 1.36361655 |
| 64 | * MP0005551_abnormal_eye_electrophysiolog | 1.35210533 |
| 65 | MP0003633_abnormal_nervous_system | 1.34523186 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.34361201 |
| 67 | MP0002419_abnormal_innate_immunity | 1.33014294 |
| 68 | MP0005646_abnormal_pituitary_gland | 1.30347755 |
| 69 | MP0009278_abnormal_bone_marrow | 1.30257112 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 1.28544461 |
| 71 | MP0002998_abnormal_bone_remodeling | 1.27109138 |
| 72 | MP0001958_emphysema | 1.26713654 |
| 73 | MP0003183_abnormal_peptide_metabolism | 1.26000017 |
| 74 | MP0004264_abnormal_extraembryonic_tissu | 1.20264002 |
| 75 | MP0005257_abnormal_intraocular_pressure | 1.20013859 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.16367170 |
| 77 | MP0002152_abnormal_brain_morphology | 1.15794908 |
| 78 | MP0000013_abnormal_adipose_tissue | 1.14269541 |
| 79 | MP0005025_abnormal_response_to | 1.12588473 |
| 80 | MP0003631_nervous_system_phenotype | 1.10681621 |
| 81 | MP0005166_decreased_susceptibility_to | 1.10391496 |
| 82 | MP0005645_abnormal_hypothalamus_physiol | 1.09601796 |
| 83 | MP0005464_abnormal_platelet_physiology | 1.08840349 |
| 84 | MP0000751_myopathy | 1.07244144 |
| 85 | MP0000579_abnormal_nail_morphology | 1.07216255 |
| 86 | MP0001529_abnormal_vocalization | 1.06149604 |
| 87 | MP0008961_abnormal_basal_metabolism | 1.05905621 |
| 88 | MP0005023_abnormal_wound_healing | 1.03913946 |
| 89 | MP0006082_CNS_inflammation | 1.03859662 |
| 90 | MP0002089_abnormal_postnatal_growth/wei | 1.03115913 |
| 91 | MP0004142_abnormal_muscle_tone | 1.02885514 |
| 92 | MP0000678_abnormal_parathyroid_gland | 1.02295685 |
| 93 | MP0000604_amyloidosis | 1.01426671 |
| 94 | * MP0002229_neurodegeneration | 1.00955783 |
| 95 | MP0001905_abnormal_dopamine_level | 1.00270339 |
| 96 | MP0003828_pulmonary_edema | 0.97563864 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.96341538 |
| 98 | MP0003283_abnormal_digestive_organ | 0.95269771 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.94279563 |
| 100 | MP0002069_abnormal_eating/drinking_beha | 0.93400134 |
| 101 | MP0008874_decreased_physiological_sensi | 0.92750047 |
| 102 | MP0008438_abnormal_cutaneous_collagen | 0.92310521 |
| 103 | MP0004510_myositis | 0.91424175 |
| 104 | MP0001177_atelectasis | 0.90732358 |
| 105 | MP0004742_abnormal_vestibular_system | 0.90644048 |
| 106 | MP0008872_abnormal_physiological_respon | 0.90516173 |
| 107 | * MP0003634_abnormal_glial_cell | 0.88800160 |
| 108 | * MP0002090_abnormal_vision | 0.88612627 |
| 109 | MP0005666_abnormal_adipose_tissue | 0.86557095 |
| 110 | MP0001188_hyperpigmentation | 0.84940263 |
| 111 | MP0005394_taste/olfaction_phenotype | 0.84664021 |
| 112 | MP0005499_abnormal_olfactory_system | 0.84664021 |
| 113 | MP0005535_abnormal_body_temperature | 0.84145397 |
| 114 | MP0005000_abnormal_immune_tolerance | 0.83396363 |
| 115 | MP0002896_abnormal_bone_mineralization | 0.82984869 |
| 116 | MP0003724_increased_susceptibility_to | 0.82610397 |
| 117 | MP0003279_aneurysm | 0.82267478 |
| 118 | MP0005501_abnormal_skin_physiology | 0.82125427 |
| 119 | MP0004085_abnormal_heartbeat | 0.81756569 |
| 120 | MP0006072_abnormal_retinal_apoptosis | 0.81347020 |
| 121 | MP0001851_eye_inflammation | 0.80994849 |
| 122 | MP0000343_altered_response_to | 0.80924656 |
| 123 | MP0005187_abnormal_penis_morphology | 0.80873674 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.80836093 |
| 125 | MP0004381_abnormal_hair_follicle | 0.78962037 |
| 126 | MP0003632_abnormal_nervous_system | 0.78507944 |
| 127 | MP0004233_abnormal_muscle_weight | 0.78046789 |
| 128 | MP0003866_abnormal_defecation | 0.77878574 |
| 129 | * MP0002752_abnormal_somatic_nervous | 0.76835652 |
| 130 | MP0003075_altered_response_to | 0.76758659 |
| 131 | MP0002837_dystrophic_cardiac_calcinosis | 0.76611015 |
| 132 | MP0010155_abnormal_intestine_physiology | 0.76246371 |
| 133 | MP0002638_abnormal_pupillary_reflex | 0.76018042 |
| 134 | MP0005387_immune_system_phenotype | 0.75932048 |
| 135 | MP0001790_abnormal_immune_system | 0.75932048 |
| 136 | MP0000685_abnormal_immune_system | 0.75817805 |
| 137 | MP0002060_abnormal_skin_morphology | 0.75046605 |
| 138 | MP0000631_abnormal_neuroendocrine_gland | 0.75004586 |
| 139 | MP0003303_peritoneal_inflammation | 0.74237494 |
| 140 | MP0003690_abnormal_glial_cell | 0.73657068 |
| 141 | MP0004215_abnormal_myocardial_fiber | 0.73366202 |
| 142 | MP0005621_abnormal_cell_physiology | 0.72990183 |
| 143 | MP0001216_abnormal_epidermal_layer | 0.72925019 |
| 144 | MP0005623_abnormal_meninges_morphology | 0.72821208 |
| 145 | MP0003448_altered_tumor_morphology | 0.72328953 |
| 146 | MP0004145_abnormal_muscle_electrophysio | 0.72147585 |
| 147 | MP0005375_adipose_tissue_phenotype | 0.69638390 |
| 148 | MP0005310_abnormal_salivary_gland | 0.69630234 |
| 149 | MP0005253_abnormal_eye_physiology | 0.68903718 |
| 150 | MP0004484_altered_response_of | 0.68726809 |
| 151 | MP0003045_fibrosis | 0.68469819 |
| 152 | MP0001915_intracranial_hemorrhage | 0.66125995 |
| 153 | MP0000920_abnormal_myelination | 0.65130411 |
| 154 | MP0004130_abnormal_muscle_cell | 0.65075875 |
| 155 | MP0001819_abnormal_immune_cell | 0.63942531 |
| 156 | MP0002420_abnormal_adaptive_immunity | 0.63736543 |
| 157 | MP0001299_abnormal_eye_distance/ | 0.63463374 |
| 158 | MP0003137_abnormal_impulse_conducting | 0.62372507 |
| 159 | MP0000681_abnormal_thyroid_gland | 0.61408069 |
| 160 | MP0001943_abnormal_respiration | 0.61350300 |
| 161 | MP0003861_abnormal_nervous_system | 0.60734152 |
| 162 | * MP0001963_abnormal_hearing_physiology | 0.60191035 |
| 163 | MP0005165_increased_susceptibility_to | 0.59927953 |
| 164 | MP0002148_abnormal_hypersensitivity_rea | 0.59449196 |
| 165 | MP0009785_altered_susceptibility_to | 0.58868967 |
| 166 | MP0002452_abnormal_antigen_presenting | 0.58472041 |
| 167 | MP0000767_abnormal_smooth_muscle | 0.58073295 |
| 168 | MP0010769_abnormal_survival | 0.57423862 |
| 169 | MP0005167_abnormal_blood-brain_barrier | 0.57097993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.68328370 |
| 2 | Myokymia (HP:0002411) | 5.92815784 |
| 3 | Focal seizures (HP:0007359) | 5.36503209 |
| 4 | * Visual hallucinations (HP:0002367) | 4.54827694 |
| 5 | Epileptic encephalopathy (HP:0200134) | 4.35810924 |
| 6 | Progressive cerebellar ataxia (HP:0002073) | 4.31121451 |
| 7 | Atonic seizures (HP:0010819) | 4.21356526 |
| 8 | Absence seizures (HP:0002121) | 4.10586255 |
| 9 | Febrile seizures (HP:0002373) | 3.96237617 |
| 10 | Action tremor (HP:0002345) | 3.87022708 |
| 11 | Supranuclear gaze palsy (HP:0000605) | 3.79822259 |
| 12 | Mutism (HP:0002300) | 3.75073943 |
| 13 | Ankle clonus (HP:0011448) | 3.67333243 |
| 14 | Dialeptic seizures (HP:0011146) | 3.62995906 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.61114112 |
| 16 | Papilledema (HP:0001085) | 3.44159959 |
| 17 | Poor eye contact (HP:0000817) | 3.22300872 |
| 18 | Broad-based gait (HP:0002136) | 3.21574768 |
| 19 | Truncal ataxia (HP:0002078) | 3.14653193 |
| 20 | Impaired social interactions (HP:0000735) | 3.09370734 |
| 21 | Abnormal social behavior (HP:0012433) | 3.09370734 |
| 22 | Obstructive sleep apnea (HP:0002870) | 3.07738928 |
| 23 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.05500888 |
| 24 | Dysdiadochokinesis (HP:0002075) | 2.98355809 |
| 25 | * Depression (HP:0000716) | 2.97533334 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.95196048 |
| 27 | Eczematoid dermatitis (HP:0000976) | 2.92264142 |
| 28 | Genetic anticipation (HP:0003743) | 2.88491396 |
| 29 | Gaze-evoked nystagmus (HP:0000640) | 2.85445815 |
| 30 | Hyperacusis (HP:0010780) | 2.85303707 |
| 31 | Abnormal eating behavior (HP:0100738) | 2.84074457 |
| 32 | Urinary urgency (HP:0000012) | 2.84068903 |
| 33 | Excessive salivation (HP:0003781) | 2.77852617 |
| 34 | Drooling (HP:0002307) | 2.77852617 |
| 35 | Postural instability (HP:0002172) | 2.77616376 |
| 36 | Anxiety (HP:0000739) | 2.76146716 |
| 37 | Progressive inability to walk (HP:0002505) | 2.75073488 |
| 38 | Amblyopia (HP:0000646) | 2.68506074 |
| 39 | Cerebral inclusion bodies (HP:0100314) | 2.68337964 |
| 40 | Limb dystonia (HP:0002451) | 2.67305867 |
| 41 | Dysmetria (HP:0001310) | 2.66773444 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.64299600 |
| 43 | Insidious onset (HP:0003587) | 2.62641506 |
| 44 | Termporal pattern (HP:0011008) | 2.62641506 |
| 45 | Diplopia (HP:0000651) | 2.62239405 |
| 46 | Abnormality of binocular vision (HP:0011514) | 2.62239405 |
| 47 | Impaired smooth pursuit (HP:0007772) | 2.56261733 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.53708005 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.53708005 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.53708005 |
| 51 | Hemiplegia (HP:0002301) | 2.51638264 |
| 52 | Neurofibrillary tangles (HP:0002185) | 2.51159125 |
| 53 | Spastic gait (HP:0002064) | 2.50608447 |
| 54 | Scanning speech (HP:0002168) | 2.49589154 |
| 55 | Amyotrophic lateral sclerosis (HP:0007354) | 2.48514958 |
| 56 | Hemiparesis (HP:0001269) | 2.47597158 |
| 57 | Abnormality of the lower motor neuron (HP:0002366) | 2.46891262 |
| 58 | Dysostosis multiplex (HP:0000943) | 2.44443861 |
| 59 | Stereotypic behavior (HP:0000733) | 2.40978462 |
| 60 | Hyperventilation (HP:0002883) | 2.40566297 |
| 61 | Upper limb amyotrophy (HP:0009129) | 2.40341654 |
| 62 | Distal upper limb amyotrophy (HP:0007149) | 2.40341654 |
| 63 | Torticollis (HP:0000473) | 2.40023128 |
| 64 | Dysmetric saccades (HP:0000641) | 2.39396604 |
| 65 | Central scotoma (HP:0000603) | 2.38485939 |
| 66 | Inappropriate behavior (HP:0000719) | 2.37737046 |
| 67 | Bradykinesia (HP:0002067) | 2.37586701 |
| 68 | Abnormality of the corticospinal tract (HP:0002492) | 2.37302516 |
| 69 | Pheochromocytoma (HP:0002666) | 2.36907936 |
| 70 | Abnormality of macrophages (HP:0004311) | 2.36407656 |
| 71 | Agitation (HP:0000713) | 2.35569563 |
| 72 | Epileptiform EEG discharges (HP:0011182) | 2.34763737 |
| 73 | Intention tremor (HP:0002080) | 2.33220961 |
| 74 | EEG with generalized epileptiform discharges (HP:0011198) | 2.32528612 |
| 75 | Distal lower limb amyotrophy (HP:0008944) | 2.30471797 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.29997911 |
| 77 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.28131319 |
| 78 | Vertebral compression fractures (HP:0002953) | 2.25646958 |
| 79 | Pointed chin (HP:0000307) | 2.25484756 |
| 80 | Polyphagia (HP:0002591) | 2.25416288 |
| 81 | Thin bony cortex (HP:0002753) | 2.23920123 |
| 82 | Axonal loss (HP:0003447) | 2.23676983 |
| 83 | Broad face (HP:0000283) | 2.23252487 |
| 84 | Apathy (HP:0000741) | 2.23120876 |
| 85 | Hypsarrhythmia (HP:0002521) | 2.22651807 |
| 86 | Megalencephaly (HP:0001355) | 2.21621925 |
| 87 | Lower limb muscle weakness (HP:0007340) | 2.21397597 |
| 88 | Flat acetabular roof (HP:0003180) | 2.16133588 |
| 89 | Protrusio acetabuli (HP:0003179) | 2.14654511 |
| 90 | Focal dystonia (HP:0004373) | 2.14205207 |
| 91 | Amyloidosis (HP:0011034) | 2.14194421 |
| 92 | Insomnia (HP:0100785) | 2.14152267 |
| 93 | Achilles tendon contracture (HP:0001771) | 2.13873019 |
| 94 | Hyperparathyroidism (HP:0000843) | 2.13236392 |
| 95 | Absent speech (HP:0001344) | 2.12877309 |
| 96 | Hypoventilation (HP:0002791) | 2.12615524 |
| 97 | Distal lower limb muscle weakness (HP:0009053) | 2.11846307 |
| 98 | Cellulitis (HP:0100658) | 2.10675240 |
| 99 | Neuronal loss in central nervous system (HP:0002529) | 2.10492647 |
| 100 | Annular pancreas (HP:0001734) | 2.10363514 |
| 101 | Loss of speech (HP:0002371) | 2.06846462 |
| 102 | Ventricular fibrillation (HP:0001663) | 2.06456724 |
| 103 | Generalized myoclonic seizures (HP:0002123) | 2.03314798 |
| 104 | Status epilepticus (HP:0002133) | 2.03158138 |
| 105 | Recurrent bacterial skin infections (HP:0005406) | 2.02965633 |
| 106 | Neuroendocrine neoplasm (HP:0100634) | 2.01771042 |
| 107 | Failure to thrive in infancy (HP:0001531) | 2.01484939 |
| 108 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.00810028 |
| 109 | Mucopolysacchariduria (HP:0008155) | 2.00810028 |
| 110 | Diminished motivation (HP:0000745) | 2.00370628 |
| 111 | Recurrent abscess formation (HP:0002722) | 2.00203136 |
| 112 | Interstitial pulmonary disease (HP:0006530) | 2.00010377 |
| 113 | Inability to walk (HP:0002540) | 1.99049894 |
| 114 | Hand muscle atrophy (HP:0009130) | 1.97693758 |
| 115 | Akinesia (HP:0002304) | 1.97441660 |
| 116 | Increased connective tissue (HP:0009025) | 1.97395403 |
| 117 | Clonus (HP:0002169) | 1.96443241 |
| 118 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.95750147 |
| 119 | Gingivitis (HP:0000230) | 1.94571641 |
| 120 | Slow saccadic eye movements (HP:0000514) | 1.94555218 |
| 121 | Lower limb asymmetry (HP:0100559) | 1.94396207 |
| 122 | Deep venous thrombosis (HP:0002625) | 1.92138529 |
| 123 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90681514 |
| 124 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90681514 |
| 125 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90681514 |
| 126 | Impaired vibratory sensation (HP:0002495) | 1.90220220 |
| 127 | Abnormality of the Achilles tendon (HP:0005109) | 1.90180123 |
| 128 | Craniofacial dystonia (HP:0012179) | 1.89690932 |
| 129 | Lower limb amyotrophy (HP:0007210) | 1.89350326 |
| 130 | Arterial tortuosity (HP:0005116) | 1.89063462 |
| 131 | Atrophic scars (HP:0001075) | 1.87505848 |
| 132 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.86130390 |
| 133 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.84960261 |
| 134 | Hypercortisolism (HP:0001578) | 1.84511560 |
| 135 | Abnormality of macular pigmentation (HP:0008002) | 1.83525854 |
| 136 | Ankyloglossia (HP:0010296) | 1.82531861 |
| 137 | Abnormality of salivation (HP:0100755) | 1.82058550 |
| 138 | Polygenic inheritance (HP:0010982) | 1.81926287 |
| 139 | Macroorchidism (HP:0000053) | 1.81876429 |
| 140 | Gait ataxia (HP:0002066) | 1.81771037 |
| 141 | Long palpebral fissure (HP:0000637) | 1.81037182 |
| 142 | Premature rupture of membranes (HP:0001788) | 1.80353354 |
| 143 | Psychosis (HP:0000709) | 1.80136595 |
| 144 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.78984055 |
| 145 | Short nail (HP:0001799) | 1.78117657 |
| 146 | Postural tremor (HP:0002174) | 1.77666874 |
| 147 | Difficulty climbing stairs (HP:0003551) | 1.76882761 |
| 148 | Decreased motor nerve conduction velocity (HP:0003431) | 1.76578952 |
| 149 | Intellectual disability, profound (HP:0002187) | 1.75280941 |
| 150 | Fragile skin (HP:0001030) | 1.74844682 |
| 151 | Rigidity (HP:0002063) | 1.74182639 |
| 152 | Mitral regurgitation (HP:0001653) | 1.72569466 |
| 153 | Upper motor neuron abnormality (HP:0002127) | 1.70880010 |
| 154 | Nuclear cataract (HP:0100018) | 1.70760288 |
| 155 | Vascular tortuosity (HP:0004948) | 1.70701464 |
| 156 | Onion bulb formation (HP:0003383) | 1.69938213 |
| 157 | Distal sensory impairment (HP:0002936) | 1.69473027 |
| 158 | Pathologic fracture (HP:0002756) | 1.69457432 |
| 159 | Bone pain (HP:0002653) | 1.69308590 |
| 160 | Hemorrhage of the eye (HP:0011885) | 1.68179591 |
| 161 | Supernumerary nipples (HP:0002558) | 1.67757186 |
| 162 | Peripheral hypomyelination (HP:0007182) | 1.66604071 |
| 163 | Spinal cord compression (HP:0002176) | 1.66120422 |
| 164 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.65741295 |
| 165 | Increased IgE level (HP:0003212) | 1.65486853 |
| 166 | Disproportionate tall stature (HP:0001519) | 1.62237897 |
| 167 | * Rapidly progressive (HP:0003678) | 1.61666435 |
| 168 | Ulnar bowing (HP:0003031) | 1.59960461 |
| 169 | Abnormality of oral frenula (HP:0000190) | 1.59832057 |
| 170 | Growth hormone excess (HP:0000845) | 1.58832577 |
| 171 | Abnormality of nail color (HP:0100643) | 1.58203307 |
| 172 | Aneurysm (HP:0002617) | 1.57649210 |
| 173 | Foot dorsiflexor weakness (HP:0009027) | 1.57395141 |
| 174 | * Dementia (HP:0000726) | 1.57325581 |
| 175 | Systemic lupus erythematosus (HP:0002725) | 1.56923417 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.18708228 |
| 2 | NTRK3 | 4.10398348 |
| 3 | MAP3K9 | 3.93519376 |
| 4 | EPHA4 | 3.23187712 |
| 5 | MAP3K4 | 3.04738754 |
| 6 | MINK1 | 2.90349604 |
| 7 | ICK | 2.36593509 |
| 8 | MAP2K7 | 2.33812183 |
| 9 | KSR2 | 2.33153193 |
| 10 | PAK6 | 2.33052349 |
| 11 | ERN1 | 2.30065641 |
| 12 | DAPK2 | 2.20611037 |
| 13 | IRAK3 | 2.20135132 |
| 14 | NTRK2 | 2.19509426 |
| 15 | MAP3K12 | 2.19394341 |
| 16 | SIK1 | 2.18674916 |
| 17 | SMG1 | 2.09277165 |
| 18 | CAMKK1 | 1.93957728 |
| 19 | MAP2K4 | 1.92818427 |
| 20 | NTRK1 | 1.91697825 |
| 21 | RIPK4 | 1.82133983 |
| 22 | SIK2 | 1.81977376 |
| 23 | KSR1 | 1.76815803 |
| 24 | EPHA2 | 1.68001830 |
| 25 | PRKD3 | 1.63287194 |
| 26 | MAP3K11 | 1.60281252 |
| 27 | CDK5 | 1.57526523 |
| 28 | EEF2K | 1.50203158 |
| 29 | PNCK | 1.48770558 |
| 30 | MAP2K3 | 1.43321375 |
| 31 | MAP3K2 | 1.39638665 |
| 32 | FGFR4 | 1.35650952 |
| 33 | MAPK13 | 1.33929970 |
| 34 | FES | 1.31947346 |
| 35 | PHKG1 | 1.31361444 |
| 36 | PHKG2 | 1.31361444 |
| 37 | PLK2 | 1.29500828 |
| 38 | MAP3K3 | 1.29286511 |
| 39 | GRK5 | 1.27072900 |
| 40 | STK38 | 1.25213840 |
| 41 | PDGFRA | 1.23963083 |
| 42 | DAPK1 | 1.23690412 |
| 43 | EPHB1 | 1.21128131 |
| 44 | RET | 1.20459163 |
| 45 | TTN | 1.15589894 |
| 46 | CDK12 | 1.14805389 |
| 47 | PRKCH | 1.13215933 |
| 48 | PRKCG | 1.09513260 |
| 49 | CAMKK2 | 1.08743548 |
| 50 | TNIK | 1.07232252 |
| 51 | TESK1 | 1.04861417 |
| 52 | PTK6 | 1.04650364 |
| 53 | TYRO3 | 1.04616751 |
| 54 | UHMK1 | 1.04095516 |
| 55 | CASK | 1.03194380 |
| 56 | PRKD2 | 1.02437655 |
| 57 | TAOK2 | 1.02287726 |
| 58 | LATS2 | 1.00590003 |
| 59 | CDK19 | 1.00256100 |
| 60 | SCYL2 | 0.99929641 |
| 61 | STK11 | 0.97821389 |
| 62 | IRAK2 | 0.97190797 |
| 63 | ALK | 0.96754259 |
| 64 | PAK3 | 0.94777540 |
| 65 | CSNK1G2 | 0.91754934 |
| 66 | RIPK1 | 0.91406390 |
| 67 | TAOK1 | 0.90142395 |
| 68 | PTK2 | 0.88533688 |
| 69 | CAMK2A | 0.88397531 |
| 70 | CDK14 | 0.87691999 |
| 71 | CDK18 | 0.87539519 |
| 72 | CDK15 | 0.87419350 |
| 73 | SGK223 | 0.87369376 |
| 74 | SGK494 | 0.87369376 |
| 75 | CAMK1G | 0.87329251 |
| 76 | PRPF4B | 0.87038442 |
| 77 | CSK | 0.84618610 |
| 78 | ZAP70 | 0.83458038 |
| 79 | DYRK1A | 0.82021621 |
| 80 | MAP3K13 | 0.81176907 |
| 81 | BLK | 0.81132939 |
| 82 | BRAF | 0.80529413 |
| 83 | CAMK1 | 0.78801141 |
| 84 | SGK2 | 0.77201641 |
| 85 | TYK2 | 0.77178353 |
| 86 | PAK4 | 0.76685730 |
| 87 | NME2 | 0.76684260 |
| 88 | IRAK4 | 0.76666848 |
| 89 | SGK3 | 0.76572996 |
| 90 | ARAF | 0.75732557 |
| 91 | CDK11A | 0.75196747 |
| 92 | MAP4K1 | 0.74318769 |
| 93 | MST1R | 0.74222687 |
| 94 | RAF1 | 0.73452112 |
| 95 | LMTK2 | 0.72436284 |
| 96 | ERBB3 | 0.72204515 |
| 97 | DDR2 | 0.71748204 |
| 98 | TESK2 | 0.71246501 |
| 99 | MOS | 0.70828106 |
| 100 | MARK2 | 0.69598114 |
| 101 | CAMK1D | 0.68881070 |
| 102 | MTOR | 0.68103839 |
| 103 | MAP3K1 | 0.65268433 |
| 104 | TBK1 | 0.64323949 |
| 105 | PRKCZ | 0.61925526 |
| 106 | JAK1 | 0.61057372 |
| 107 | CAMK2B | 0.60882689 |
| 108 | PRKG2 | 0.60592138 |
| 109 | FER | 0.58950553 |
| 110 | RPS6KA2 | 0.58879430 |
| 111 | * SGK1 | 0.58841196 |
| 112 | PDK1 | 0.57759089 |
| 113 | TRIB3 | 0.57032038 |
| 114 | FYN | 0.56905775 |
| 115 | GRK6 | 0.55337961 |
| 116 | NEK6 | 0.52158008 |
| 117 | PTK2B | 0.51723435 |
| 118 | PRKCE | 0.51702085 |
| 119 | FGFR3 | 0.51451019 |
| 120 | MAP3K14 | 0.50647907 |
| 121 | PDPK1 | 0.49732349 |
| 122 | WNK1 | 0.49089966 |
| 123 | TNK2 | 0.48870895 |
| 124 | LRRK2 | 0.48650744 |
| 125 | MAP2K1 | 0.48625926 |
| 126 | PDGFRB | 0.47400915 |
| 127 | JAK2 | 0.47071957 |
| 128 | * RPS6KA3 | 0.46556083 |
| 129 | RPS6KC1 | 0.46430224 |
| 130 | RPS6KL1 | 0.46430224 |
| 131 | MAPK10 | 0.45063105 |
| 132 | HIPK2 | 0.44960040 |
| 133 | PKN2 | 0.42457636 |
| 134 | FGFR2 | 0.42339678 |
| 135 | CDC42BPA | 0.42014854 |
| 136 | CAMK2D | 0.40116848 |
| 137 | MAP3K7 | 0.39933308 |
| 138 | NEK1 | 0.39419918 |
| 139 | MAPK12 | 0.37722763 |
| 140 | PRKCB | 0.37477898 |
| 141 | CAMK4 | 0.37135973 |
| 142 | BMPR2 | 0.37095110 |
| 143 | FGR | 0.35996743 |
| 144 | MAP3K6 | 0.35651585 |
| 145 | ROCK2 | 0.34852988 |
| 146 | CSNK1G3 | 0.33318998 |
| 147 | PINK1 | 0.31728554 |
| 148 | CAMK2G | 0.30680629 |
| 149 | DAPK3 | 0.29570921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.34242935 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.18282927 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.59521334 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.50929205 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.48594104 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.46203885 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.42549254 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.37343217 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.37299590 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.29954940 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23860296 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.09549168 |
| 13 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.08967781 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.96240045 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.91529504 |
| 16 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90414850 |
| 17 | Insulin secretion_Homo sapiens_hsa04911 | 1.81283382 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76131239 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70777430 |
| 20 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66722634 |
| 21 | Renin secretion_Homo sapiens_hsa04924 | 1.66600192 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.66490557 |
| 23 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.60661875 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56626710 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.52532337 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.49383996 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.47630333 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.45552379 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.45222808 |
| 30 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.42868319 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.39774597 |
| 32 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.39330238 |
| 33 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.38340797 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.37474360 |
| 35 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.36833142 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33327204 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.31936290 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28169365 |
| 39 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27830836 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26925717 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.23945496 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23394318 |
| 43 | Glioma_Homo sapiens_hsa05214 | 1.22120375 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.20434000 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.17192587 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17190886 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14852038 |
| 48 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.14304005 |
| 49 | Axon guidance_Homo sapiens_hsa04360 | 1.13841298 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.12598986 |
| 51 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.11892073 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11725779 |
| 53 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.10553323 |
| 54 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.07013226 |
| 55 | Bladder cancer_Homo sapiens_hsa05219 | 1.06922668 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 1.02778501 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02692332 |
| 58 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02373355 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00938052 |
| 60 | Melanogenesis_Homo sapiens_hsa04916 | 0.99267776 |
| 61 | Tuberculosis_Homo sapiens_hsa05152 | 0.99059448 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.98519978 |
| 63 | Hepatitis C_Homo sapiens_hsa05160 | 0.92462212 |
| 64 | Leishmaniasis_Homo sapiens_hsa05140 | 0.90509866 |
| 65 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89644973 |
| 66 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89002414 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88947798 |
| 68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.88685107 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85736922 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.85351251 |
| 71 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.81805493 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81583081 |
| 73 | Focal adhesion_Homo sapiens_hsa04510 | 0.81548147 |
| 74 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81277997 |
| 75 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80835256 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.80172215 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.80019248 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.78871591 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78663678 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.78236041 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77908175 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76940215 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.76661921 |
| 84 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.76404467 |
| 85 | Phagosome_Homo sapiens_hsa04145 | 0.75789924 |
| 86 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75766667 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75549789 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.75224522 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74987313 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.74878149 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74589656 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.74540003 |
| 93 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71274393 |
| 94 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68494043 |
| 95 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68483432 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.68439092 |
| 97 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.66290006 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.64819617 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64064229 |
| 100 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63875227 |
| 101 | Pertussis_Homo sapiens_hsa05133 | 0.63308794 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63008871 |
| 103 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62838867 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62377179 |
| 105 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61870846 |
| 106 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.61370800 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60441086 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60374582 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.58886594 |
| 110 | Influenza A_Homo sapiens_hsa05164 | 0.57983949 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.57712201 |
| 112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57189657 |
| 113 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57113252 |
| 114 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56705159 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.54940627 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.53215378 |
| 117 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52990691 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.52690358 |
| 119 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52106208 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51893426 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51768122 |
| 122 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51757395 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51570102 |
| 124 | Alcoholism_Homo sapiens_hsa05034 | 0.50170262 |
| 125 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.50145348 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.48515283 |
| 127 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.47571230 |
| 128 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.46315574 |
| 129 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43363805 |
| 130 | Platelet activation_Homo sapiens_hsa04611 | 0.43026840 |
| 131 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42599407 |
| 132 | Prion diseases_Homo sapiens_hsa05020 | 0.42310306 |
| 133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.41325164 |
| 134 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.40763975 |
| 135 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38143692 |
| 136 | Bile secretion_Homo sapiens_hsa04976 | 0.37081369 |
| 137 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37075136 |
| 138 | Circadian rhythm_Homo sapiens_hsa04710 | 0.35768449 |
| 139 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.35155837 |
| 140 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29288794 |

